Combinations will lead the way in immunotherapy for bladder cancer

by Rahul Ravind
Published 2020-01-01

Systemic treatment options in bladder cancer

by Rahul Ravind, Kumar Prabhash, Amit Joshi, Vijay Patil, Vanita Noronha
Published 2018-01-01

Low-cost oral metronomic chemotherapy versus intravenous cisplatin in patients with recurrent, metastatic, inoperable head and neck carcinoma: an open-label, parallel-group, non-in...

by Vijay Patil, ProfDM, Vanita Noronha, ProfDM, Sachin Babanrao Dhumal, BHMS, Amit Joshi, ProfDM, Nandini Menon, DNB, Atanu Bhattacharjee, PhD, Suyash Kulkarni, ProfMD, Suman Kumar Ankathi, MD, Abhishek Mahajan, ProfMD, Nilesh Sable, ProfMD, Kavita Nawale, MBA, Arti Bhelekar, MSc, Sadaf Mukadam, MSc, Arun Chandrasekharan, DM, Sudeep Das, DM, Dilip Vallathol, DM, Hollis D'Souza, DM, Amit Kumar, DM, Amit Agrawal, MD, Satvik Khaddar, MD, Narmadha Rathnasamy, MD, Ramnath Shenoy, MD, Lakhan Kashyap, MD, Rahul Kumar Rai, MD, George Abraham, MD, Saswata Saha, MD, Swaratika Majumdar, DM, Naveen Karuvandan, MD, Vijai Simha, DM, Vasu Babu, MD, Prahalad Elamarthi, MD, Annu Rajpurohit, MD, Kanteti Aditya Pavan Kumar, MD, Anne Srikanth, MD, Rahul Ravind, MD, Shripad Banavali, ProfMD, Kumar Prabhash, ProfDM
Published 2020-09-01